BACKGROUND: Continuous positive airway pressure (CPAP) is an effective treatment for obstructive sleep apnea (OSA). However, compliance is a significant problem and has been incompletely assessed in long-term studies. OBJECTIVE: To assess the long-term compliance of OSA patients with CPAP therapy. SUBJECTS: Eighty patients who had had a diagnosis of OSA at least four years previously and received a written prescription for CPAP were evaluated. METHODS: Subjects were identified by reviewing sleep laboratory records. Participants were contacted by telephone and were asked to quantitate their CPAP use (hours per night, nights per week) and to evaluate whether there had been improvement in symptoms. Those who commenced but subsequently abandoned therapy and those who never initiated treatment were questioned about their reasons for noncompliance. RESULTS: Patient demographics included mean (+/- SD) age (58+/-11 years), male sex (70 of 80 patients [88%]) and mean apnea-hypopnea index (70+/-44 events/h). At the time of the interview (64.0+/-3.7 months after diagnosis), 43 of 80 patients (54%) were still using CPAP and most reported an improvement in symptoms. Twelve of 80 patients (15%) had abandoned CPAP after using it for 10.1+/-15.5 months, and 25 of 80 patients (31%) had never commenced therapy after initial diagnosis and CPAP titration. Analysis of scores reflecting initial patient sleepiness revealed a significant association of this symptom with subsequent CPAP compliance. CONCLUSION: Although many patients with OSA derive subjective benefit from, and adhere to treatment with CPAP, a significant proportion of those so diagnosed either do not initiate or eventually abandon therapy. Initial experience with CPAP appears to be important, reinforcing the need for early education and support in these patients.
BACKGROUND: Continuous positive airway pressure (CPAP) is an effective treatment for obstructive sleep apnea (OSA). However, compliance is a significant problem and has been incompletely assessed in long-term studies. OBJECTIVE: To assess the long-term compliance of OSA patients with CPAP therapy. SUBJECTS: Eighty patients who had had a diagnosis of OSA at least four years previously and received a written prescription for CPAP were evaluated. METHODS: Subjects were identified by reviewing sleep laboratory records. Participants were contacted by telephone and were asked to quantitate their CPAP use (hours per night, nights per week) and to evaluate whether there had been improvement in symptoms. Those who commenced but subsequently abandoned therapy and those who never initiated treatment were questioned about their reasons for noncompliance. RESULTS:Patient demographics included mean (+/- SD) age (58+/-11 years), male sex (70 of 80 patients [88%]) and mean apnea-hypopnea index (70+/-44 events/h). At the time of the interview (64.0+/-3.7 months after diagnosis), 43 of 80 patients (54%) were still using CPAP and most reported an improvement in symptoms. Twelve of 80 patients (15%) had abandoned CPAP after using it for 10.1+/-15.5 months, and 25 of 80 patients (31%) had never commenced therapy after initial diagnosis and CPAP titration. Analysis of scores reflecting initial patientsleepiness revealed a significant association of this symptom with subsequent CPAP compliance. CONCLUSION: Although many patients with OSA derive subjective benefit from, and adhere to treatment with CPAP, a significant proportion of those so diagnosed either do not initiate or eventually abandon therapy. Initial experience with CPAP appears to be important, reinforcing the need for early education and support in these patients.
Authors: C Barjhoux; J L Pépin; C Deschaux-Blanc; M Kulpa; A Cornette; B Desrues; C Girault; B Gauzere; J M Bedicam; A Greil Journal: Rev Mal Respir Date: 1994 Impact factor: 0.622
Authors: Wietske Richard; Jantine Venker; Cindy den Herder; Dennis Kox; Bob van den Berg; Martin Laman; Harm van Tinteren; Nico de Vries Journal: Eur Arch Otorhinolaryngol Date: 2007-04-19 Impact factor: 2.503
Authors: Rohit Budhiraja; Sairam Parthasarathy; Christopher L Drake; Thomas Roth; Imran Sharief; Pooja Budhiraja; Victoria Saunders; David W Hudgel Journal: Sleep Date: 2007-03 Impact factor: 5.849
Authors: Andrey Zinchuk; Bradley A Edwards; Sangchoon Jeon; Brian B Koo; John Concato; Scott Sands; Andrew Wellman; Henry K Yaggi Journal: J Clin Sleep Med Date: 2018-05-15 Impact factor: 4.062
Authors: Lien Desteghe; Jeroen M L Hendriks; R Doug McEvoy; Ching Li Chai-Coetzer; Paul Dendale; Prashanthan Sanders; Hein Heidbuchel; Dominik Linz Journal: Clin Res Cardiol Date: 2018-04-12 Impact factor: 5.460
Authors: David G McSharry; Julian P Saboisky; Pam Deyoung; Amy S Jordan; John Trinder; Erik Smales; Lauren Hess; Nancy L Chamberlin; Atul Malhotra Journal: Sleep Date: 2014-03-01 Impact factor: 5.849
Authors: Skai W Schwartz; Julie Rosas; Michelle R Iannacone; Philip R Foulis; W McDowell Anderson Journal: J Clin Sleep Med Date: 2013-04-15 Impact factor: 4.062
Authors: Jeffrey D Dawson; Lixi Yu; Nazan S Aksan; Jon Tippin; Matthew Rizzo; Steven W Anderson Journal: Proc Int Driv Symp Hum Factors Driv Assess Train Veh Des Date: 2015-06